Structure-activity relationships of competitive NMDA receptor antagonists

被引:5
作者
Cheung, NS
OCallaghan, D
Ryan, MC
Dutton, R
Wong, MG
Beart, PM
机构
[1] MONASH UNIV,DEPT PHARMACOL,CLAYTON,VIC 3168,AUSTRALIA
[2] UNIV MELBOURNE,AUSTIN HOSP,DEPT MED,HEIDELBERG,VIC 3084,AUSTRALIA
[3] SWINBURNE UNIV TECHNOL,DEPT APPL CHEM,HAWTHORN,VIC 3122,AUSTRALIA
关键词
NMDA receptor; competitive antagonist; radioligand binding; neuroprotection; molecular modelling;
D O I
10.1016/0014-2999(96)00608-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interaction of structurally constrained competitive NMDA receptor antagonists, (+/-)-cis-4-phosphonomethyl-2-piperidine carboxylic acid (CGS 19755), (2-amino-4,5-(1,2-cyclohexyl))-7-phosphonoheptanoic acid (NPC 12626), (+/-)-6-phosphonomethyl-decahydroisoquinoline-3-carboxylic acid (LY 274614), (S)-alpha-amino-5-phosphonomethyl[1,1'-biphenyl]-3-propanoic acid (SDZ EAB-515) and (S)-alpha-amino-5-phosphonomethyl[1,1':4',1 ''-terphenyl]-3-propanoic acid (SDZ 215-439), with their receptor was assessed using radioligand binding, protection against neurotoxicity in cortical neuronal cultures and computerised molecular modelling. All compounds inhibited the specific binding of [H-3]CGS 19755 and/or [H-3]CGP 39653 (inhibition constants 40-2000 nM), and protected neuronal cultures from NMDA-mediated injury (IC50 values 1.3-5.6 mu M). Quantitative conformational analyses indicated that the molecules fitted well to a NMDA receptor model. Our results draw attention to a deep hydrophobic pocket, defined by the bi- and terphenyl containing antagonists (SDZ EAB-515, SDZ 215-439), which may influence potency and selectivity.
引用
收藏
页码:159 / 162
页数:4
相关论文
共 16 条
[1]   HETEROCYCLIC AMINO-ALCOHOLS RELATED TO IFENPRODIL AS SIGMA-RECEPTOR LIGANDS - BINDING AND CONFORMATIONAL-ANALYSES [J].
BEART, PM ;
RYAN, MC ;
MERCER, LD ;
JARROTT, B ;
WONG, MG .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 269 (02) :193-200
[3]  
Buller A. L., 1993, Society for Neuroscience Abstracts, V19, P1356
[4]  
FERKANY JW, 1993, J PHARMACOL EXP THER, V264, P1993
[5]   4-(PHOSPHONOALKYL)-2-PIPERIDINECARBOXYLIC AND 4-(PHOSPHONOALKENYL)-2-PIPERIDINECARBOXYLIC ACIDS - SYNTHESIS, ACTIVITY AT N-METHYL-D-ASPARTIC ACID RECEPTORS, AND ANTICONVULSANT ACTIVITY [J].
HUTCHISON, AJ ;
WILLIAMS, M ;
ANGST, C ;
DEJESUS, R ;
BLANCHARD, L ;
JACKSON, RH ;
WILUSZ, EJ ;
MURPHY, DE ;
BERNARD, PS ;
SCHNEIDER, J ;
CAMPBELL, T ;
GUIDA, W ;
SILLS, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (09) :2171-2178
[6]  
Jane D. E., 1994, NMDA RECEPTOR, P31
[7]  
MANEV H, 1993, NEUROPHARMACOLOGY, V29, P1103
[8]   MOLECULAR DISTINCTION OF 3 N-METHYL-D-ASPARTATE-RECEPTOR SUBTYPES IN-SITU AND DEVELOPMENTAL RECEPTOR MATURATION DEMONSTRATED WITH THE PHOTOAFFINITY LIGAND I-125 LABELED CGP-55802A [J].
MARTI, T ;
BENKE, D ;
MERTENS, S ;
HECKENDORN, R ;
POZZA, M ;
ALLGEIER, H ;
ANGST, C ;
LAURIE, D ;
SEEBURG, P ;
MOHLER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) :8434-8438
[9]   N-METHYL-D-ASPARTIC ACID RECEPTOR STRUCTURE AND FUNCTION [J].
MCBAIN, CJ ;
MAYER, ML .
PHYSIOLOGICAL REVIEWS, 1994, 74 (03) :723-760
[10]   EXCITATORY AMINO-ACID NEUROTOXICITY AND NEURODEGENERATIVE DISEASE [J].
MELDRUM, B ;
GARTHWAITE, J .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (09) :379-387